Inventor · disambiguated record
Arkady Rubin
Also filed as: RUBIN ARKADY
16 granted patents·10 pending applications·61 citations·filing 1999–2023
90Inventor score
Top patents by PatentIndex Score
26 records- 0187US11116718B2Treatment of endometriosis by intravaginal administration of a low dose of a selective progesterone receptor modulator (SPRM), anti-progestin, or anti-progestational agentARSTAT INC·Filed 2019·Granted Sep 14, 2021·2 cites·6 claims
- 0285US10251836B2Treatment of endometriosis by intravaginal administration of a low dose of a selective progesterone receptor modulator (SPRM), anti-progestin, or anti-progestational agentARSTAT INC·Filed 2013·Granted Apr 9, 2019·3 cites·8 claims
- 0384US12390476B2Multiphasic contraceptive regimen for oral combination drug formulation of progestin and estrogenRUBIN ARKADY·Filed 2023·Granted Aug 19, 2025·0 cites·8 claims
- 0482US6214815B1Triphasic oral contraceptiveORTHO MCNEIL PHARM INC·Filed 1999·Granted Apr 10, 2001·56 cites·4 claims
- 0580US11833126B2Oral combination drug formulation comprising a non-steroidal anti-inflammatory drug and a complementary low dose of tranexamic acid for the treatment of menstrual pain accompanied with excessive menstrual blood lossARSTAT INC·Filed 2022·Granted Dec 5, 2023·0 cites·13 claims
- 0678US11103515B2Multiphasic contraceptive regimen for oral combination drug formulation of progestin and estrogenARSTAT INC·Filed 2019·Granted Aug 31, 2021·0 cites·12 claims
- 0777US10709679B2Oral combination drug formulation comprising a non-steroidal anti-inflammatory drug and a complementary low dose of tranexamic acid for the treatment of menstrual pain accompanied with excessive menstrual blood lossARSTAT INC·Filed 2019·Granted Jul 14, 2020·0 cites·13 claims
- 0876US11717527B2Multiphasic contraceptive regimen for oral combination drug formulation of progestin and estrogenRUBIN ARKADY·Filed 2021·Granted Aug 8, 2023·0 cites·8 claims
- 0972US11351132B2Oral combination drug formulation comprising a non-steroidal anti-inflammatory drug and a complementary low dose of tranexamic acid for the treatment of menstrual pain accompanied with excessive menstrual blood lossARSTAT INC·Filed 2020·Granted Jun 7, 2022·0 cites·13 claims
- 1071US12005138B2Treatment of endometriosis by intravaginal administration of a low dose of a selective progesterone receptor modulator (SPRM), anti-progestin, or anti-progestational agentRUBIN ARKADY·Filed 2021·Granted Jun 11, 2024·0 cites·6 claims
- 1170US10537582B2Multiphasic contraceptive regimen for oral combination drug formulation of progestin and estrogenARSTAT INC·Filed 2019·Granted Jan 21, 2020·0 cites·12 claims
- 1268US10463678B2Multiphasic contraceptive regimen for oral combination drug formulation of progestin and estrogenARSTAT INC·Filed 2018·Granted Nov 5, 2019·0 cites·6 claims
- 1367US10532037B2Oral combination drug formulation comprising a non-steroidal anti-inflammatory drug and a complementary low dose of tranexamic acid for the treatment of menstrual pain accompanied with excessive menstrual blood lossARSTAT INC·Filed 2019·Granted Jan 14, 2020·0 cites·13 claims
- 1467US10111887B2Multiphasic contraceptive regimen for oral combination drug formulation of progestin and estrogenARSTAT INC·Filed 2018·Granted Oct 30, 2018·0 cites·12 claims
- 1565US9675622B2Multiphasic contraceptive regimen for oral combination drug formulation of progestin and estrogenARSTAT INC·Filed 2014·Granted Jun 13, 2017·0 cites·12 claims
- 1664US9925199B2Multiphasic contraceptive regimen for oral combination drug formulation of progestin and estrogenARSTAT INC·Filed 2017·Granted Mar 27, 2018·0 cites·12 claims
- 1761US2019201418A1Treatment of uterine fibroids by intravaginal administration of a low dose of selective progesterone receptor modulator (sprm), anti-progestin, or anti-progestational agentARSTAT INC·Filed 2019·Application pending·0 cites
- 1860US2014039054A1Oral combination drug formulation comprising a non-steroidal anti-inflammatory drug and a complementary low dose of tranexamic acid for the treatment of menstrual pain accompanied with excessive menstrual blood lossARSTAT INC·Filed 2013·Application pending·0 cites
- 1959US2014005157A1Treatment of uterine fibroids by intravaginal administration of a low dose of selective progesterone receptor modulator (sprm), anti-progestin, or anti-progestationalARSTAT INC·Filed 2013·Application pending·0 cites
- 2059US2013345678A1Treatment of excessive menstrual blood loss by feminine sanitary products medicated with antifibrinolytic or hemostatic agentARSTAT INC·Filed 2013·Application pending·0 cites
- 2153US2019151634A1Treatment of excessive menstrual blood loss by feminine sanitary products medicated with hemostatic agentARSTAT INC·Filed 2019·Application pending·0 cites
- 2251US2005038006A1Triphasic oral contraceptiveFiled 2004·Application pending·0 cites
- 2351US2014256690A1Contraceptive methodRUBIN ARKADY·Filed 2014·Application pending·0 cites
- 2450US2014030313A1Treatment of menstrual pain and excessive menstrual blood loss by intravaginal administration of a low dose of antifibrinolytic or hemostatic agent in combination with non-steroidal anti-inflammatory drugARSTAT INC·Filed 2013·Application pending·0 cites
- 2550US2013337054A1Treatment of excessive menstrual blood loss by intravaginal administration of low doses of antifibrinolytic or hemostatic agentARSTAT INC·Filed 2013·Application pending·0 cites
- 2640US2001044429A1Triphasic oral contraceptiveFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Arkady Rubin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →